Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Johnson & Johnson settles Ohio lawsuits to avoid federal trial

Johnson & Johnson will pay $20.4 million to settle claims by two Ohio counties, allowing the U.S. healthcare giant to avoid an upcoming federal trial seeking to hold the industry responsible for the nation’s opioid epidemic.

Read More »

U.S. government gives states nearly $2 billion to combat opioid crisis

The U.S. Department of Health and Human Services will offer states more than $1.8 billion in new funding to fight the opioid epidemic.

Read More »

J&J liable in Oklahoma opioid epidemic trial

An Oklahoma judge ordered Johnson & Johnson to pay $572.1 million to the state for the company’s part in fueling an opioid epidemic by deceptively marketing addictive painkillers, a sum substantially less than investors expected, driving up J&J shares.

Read More »

Drugmaker Endo to pay $10 million to settle opioid case ahead of trial

Endo International Plc agreed to pay $10 million to avoid going to trial in October 2019 in a landmark case by two Ohio counties accusing various drug manufacturers and distributors of fueling the U.S. opioid epidemic.

Read More »

New Insights Could Lead to More Control Over Opioid Addiction

Researchers at The Scripps Research Institute in Florida published a study in the journal Science describing a newly discovered biological system that manages how cells respond to exposure to opioids.

Read More »

Second opioid distributor charged over role in U.S. drug epidemic

An Ohio drug wholesale distributor and two former executives were charged with profiting from the U.S. opioid epidemic by selling millions of pills despite signs the addictive drugs were being misused.

Read More »

U.S. overdose deaths post annual drop for first time in two decades

U.S. overdose deaths dropped during 2018 for the first time in nearly two decades, the CDC said, in a sign that a nationwide epidemic of drug-related deaths is abating.

Read More »

Lawmakers seek scientific review of plan to tightly regulate all fentanyl copycats

Lawmakers on the U.S. Senate Judiciary Committee urged the Trump administration to conduct a scientific review of a Justice Department-backed bill to classify all illicit chemical knockoffs of the potent painkiller fentanyl in the same legal category as heroin.

Read More »

States Pause Lawsuits Against Insys During Bankruptcy Proceedings

Less than a month after filing for bankruptcy, Insys Therapeutics gained a reprieve from some lawsuits as well as a path forward for regulatory approval of an opioid overdose treatment.

Read More »

Oklahoma judge approves Teva’s $85 million opioid settlement

An Oklahoma judge approved a revised $85 million (£66.7 million) settlement with Teva Pharmaceutical Industries Ltd. resolving claims by the state’s attorney general that the drugmaker helped fuel the U.S. opioid epidemic.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!

Subscribe

Ad Right Bottom